Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results

Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depressio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Health psychology Jg. 41; H. 6; S. 396
Hauptverfasser: Vatter, Sabina, Schlub, Timothy E, Napier, Christine E, Best, Megan C, Bartley, Nicci, Juraskova, Ilona, Meiser, Bettina, Ballinger, Mandy L, Biesecker, Barbara B, Goldstein, David, Thomas, David M, Butow, Phyllis
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.06.2022
ISSN:1930-7810, 1930-7810
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later. Participants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression. Approximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories. Further research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
AbstractList Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later. Participants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression. Approximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories. Further research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later.BACKGROUNDComprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later.Participants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression.METHODParticipants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression.Approximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories.RESULTSApproximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories.Further research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).CONCLUSIONFurther research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Author Thomas, David M
Butow, Phyllis
Vatter, Sabina
Napier, Christine E
Bartley, Nicci
Meiser, Bettina
Schlub, Timothy E
Biesecker, Barbara B
Best, Megan C
Juraskova, Ilona
Ballinger, Mandy L
Goldstein, David
Author_xml – sequence: 1
  givenname: Sabina
  orcidid: 0000-0001-8512-0121
  surname: Vatter
  fullname: Vatter, Sabina
  organization: Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney
– sequence: 2
  givenname: Timothy E
  orcidid: 0000-0001-7746-9649
  surname: Schlub
  fullname: Schlub, Timothy E
  organization: Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney
– sequence: 3
  givenname: Christine E
  orcidid: 0000-0001-8009-7735
  surname: Napier
  fullname: Napier, Christine E
  organization: Cancer Theme, Garvan Institute of Medical Research, St Vincents Hospital
– sequence: 4
  givenname: Megan C
  orcidid: 0000-0003-1570-8872
  surname: Best
  fullname: Best, Megan C
  organization: Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney
– sequence: 5
  givenname: Nicci
  orcidid: 0000-0001-9052-1616
  surname: Bartley
  fullname: Bartley, Nicci
  organization: Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney
– sequence: 6
  givenname: Ilona
  orcidid: 0000-0001-9396-4113
  surname: Juraskova
  fullname: Juraskova, Ilona
  organization: Centre for Medical Psychology and Evidence-Based Decision-Making (CeMPED), School of Psychology, Faculty of Science, University of Sydney
– sequence: 7
  givenname: Bettina
  orcidid: 0000-0002-5086-0784
  surname: Meiser
  fullname: Meiser, Bettina
  organization: Psychosocial Research Group, Prince of Wales Clinical School, University of New South Wales
– sequence: 8
  givenname: Mandy L
  orcidid: 0000-0002-9706-0514
  surname: Ballinger
  fullname: Ballinger, Mandy L
  organization: Cancer Theme, Garvan Institute of Medical Research, St Vincents Hospital
– sequence: 9
  givenname: Barbara B
  orcidid: 0000-0001-9665-8963
  surname: Biesecker
  fullname: Biesecker, Barbara B
  organization: Center for Newborn Screening, Ethics, and Disability Studies, RTI International
– sequence: 10
  givenname: David
  orcidid: 0000-0001-6142-3291
  surname: Goldstein
  fullname: Goldstein, David
  organization: Department of Medical Oncology, Prince of Wales Hospital
– sequence: 11
  givenname: David M
  orcidid: 0000-0002-2527-5428
  surname: Thomas
  fullname: Thomas, David M
  organization: Cancer Theme, Garvan Institute of Medical Research, St Vincents Hospital
– sequence: 12
  givenname: Phyllis
  orcidid: 0000-0003-3562-6954
  surname: Butow
  fullname: Butow, Phyllis
  organization: Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35604703$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLAzEUhYNU7EM3_gDJ0s1oHp1MZinFFxR0oeshydy0kZmkTjKF_ntTrODq3Hv4ONxz52jigweErim5o4RX91tQhBBKJT1DM1pzUlSSksm_eYrmMX5liNVleYGmvBRkWRE-Q_o9Hsw2dGHjjOpwGJMJPUTsPFbtXnkDLTZHGfBOJQc-RaxsyusABtze-Q3egA-9MziNfcjYEKzrjv4AcexSvETnVnURrk66QJ9Pjx-rl2L99vy6elgXailpKmyldQkgNK-WLVPSCmGpksC5XrJKMiFqW9KSZYNJYiyXuq6M1KLOvUQLbIFuf3PzBd8jxNT0LhroOuUhjLHJCZIxJjjN6M0JHXUPbbMbXK-GQ_P3F_YDI4hnFg
CitedBy_id crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_108215
crossref_primary_10_1111_bjhp_12773
crossref_primary_10_1136_bmjopen_2024_097620
crossref_primary_10_1136_bmjopen_2023_072472
ContentType Journal Article
CorporateAuthor Members of the PiGeOn Project
CorporateAuthor_xml – name: Members of the PiGeOn Project
DBID NPM
7X8
DOI 10.1037/hea0001181
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Public Health
Psychology
EISSN 1930-7810
ExternalDocumentID 35604703
Genre Journal Article
GrantInformation_xml – fundername: Cancer Institute NSW
– fundername: National Health and Medical Research Council
– fundername: Cancer Institute of NSW
GroupedDBID ---
--Z
-DZ
.GJ
0R~
186
29I
354
53G
5GY
5RE
5VS
7RZ
AAWTL
ABIVO
ABNCP
ABVOZ
ACGFO
ACHQT
ACPQG
ADXHL
AEHFB
AENEX
AETEA
AI.
ALMA_UNASSIGNED_HOLDINGS
AWKKM
AZXWR
CGNQK
CS3
D0L
DU5
EPA
F5P
FD6
FTD
HVGLF
HZ~
H~9
ISO
LW5
N4W
NPM
O9-
OHT
OPA
OVD
P2P
PHGZM
PHGZT
ROL
SES
SPA
TAE
TEORI
TN5
UHS
UPT
VH1
WH7
XJT
YR2
YR5
ZCA
ZGI
ZHY
ZPI
~G0
3KI
7X8
PUEGO
ID FETCH-LOGICAL-a481t-f7bb5ee6b374d2a8f66f1a8e33b42782669f5152e33280cf38b97c8b690006de2
IEDL.DBID 7X8
ISICitedReferencesCount 5
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000798615300008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1930-7810
IngestDate Sat Sep 27 21:01:11 EDT 2025
Mon Jul 21 05:55:58 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a481t-f7bb5ee6b374d2a8f66f1a8e33b42782669f5152e33280cf38b97c8b690006de2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8512-0121
0000-0002-5086-0784
0000-0001-9665-8963
0000-0001-6142-3291
0000-0003-1570-8872
0000-0001-9396-4113
0000-0001-7746-9649
0000-0002-9706-0514
0000-0001-8009-7735
0000-0003-3562-6954
0000-0001-9052-1616
0000-0002-2527-5428
OpenAccessLink http://hdl.handle.net/1959.4/unsworks_85197
PMID 35604703
PQID 2668222631
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2668222631
pubmed_primary_35604703
PublicationCentury 2000
PublicationDate 2022-06-01
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Health psychology
PublicationTitleAlternate Health Psychol
PublicationYear 2022
SSID ssj0002955
Score 2.4051318
Snippet Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted....
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 396
Title Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results
URI https://www.ncbi.nlm.nih.gov/pubmed/35604703
https://www.proquest.com/docview/2668222631
Volume 41
WOSCitedRecordID wos000798615300008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD6oExmIl3m_EcHXsjXpmvRJRBy-bOxBYW-lSRMYuHaureC_9yRtHT4Igi8thF7SJP3Ol5OT8wHc-UmC9Qu0ZyhOUYKhMl4S2BArhcZeyUgymjqxCT6ZiNksmjYOt6IJq2wx0QF1mivrI--jIbG2LGT-_fLds6pRdnW1kdDYhA5DKmNDuvhsnS2cRk71FDmKjZrzB216Usb7iHSODgn_d2rpTMxo_7-VO4C9hlySh3o0HMKGznqwM26Wz3vQ_Ya7zx7s1h47Um9EOgL5AwtJXpX4bl2QeUbaQAGi7GlFmmSsBXEK4wRBU8-tY4LYjK8LfGZZLXK8zOmB23Kc01dvZXEMr6Onl8dnr1FgwA4TfukZLuVQ61AyHqQ0ESYMjZ8IzZi0Eh342ZFBQkSxgIqBMkzIiCshQytFGqaansBWlmf6DEhCWaS5TCLjq4CrSEpu9-yGBvlmKFL_HG7bpo1xhNtliyTTeVXE68Y9h9O6f-JlnYojZkjYAgStiz_cfQldavcuOBfKFXQM_t_6GrbVRzkvVjdu6OBxMh1_ATfYz9U
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychological+outcomes+in+advanced+cancer+patients+after+receiving+genomic+tumor+profiling+results&rft.jtitle=Health+psychology&rft.au=Vatter%2C+Sabina&rft.au=Schlub%2C+Timothy+E&rft.au=Napier%2C+Christine+E&rft.au=Best%2C+Megan+C&rft.date=2022-06-01&rft.eissn=1930-7810&rft.volume=41&rft.issue=6&rft.spage=396&rft_id=info:doi/10.1037%2Fhea0001181&rft_id=info%3Apmid%2F35604703&rft_id=info%3Apmid%2F35604703&rft.externalDocID=35604703
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7810&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7810&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7810&client=summon